[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@Redeye_ "Redeye retains its positive view of Avensia despite slightly lowering our Base Case and forecasts. $AVEN"
@Redeye_ on X 2025-07-18 07:00:58 UTC 14.5K followers, XXX engagements

"Redeye updates its estimates following Waystreams Q2 report last week. $WAYS"
@Redeye_ on X 2025-07-14 06:06:27 UTC 14.5K followers, XXX engagements

"Redeye comments on CombinedXs Q2 report showing negative growth and lower margins than expected. On the positive note the underlying data looks relatively solid. $CX"
@Redeye_ on X 2025-07-17 12:32:08 UTC 14.5K followers, XXX engagements

"Redeye comments on Invisios Q2-results which saw stronger-than-expected revenue while EBITDA was lower than expected owing to a soft gross margin and somewhat higher-than-expected opex. $IVSO"
@Redeye_ on X 2025-07-18 07:21:12 UTC 14.5K followers, 1030 engagements

"Redeye shares its initial thoughts on CTEKs Q2 report which we think came in slightly softer than expected but still largely in line with our estimates on an aggregated level. $CTEK"
@Redeye_ on X 2025-07-17 07:23:20 UTC 14.5K followers, XXX engagements

"In a new research update Redeye has updated its estimates and valuation for Gaming Innovation Group after the announced acquisition of Askgamblers: $GIGSEK"
@Redeye_ on X 2022-12-21 07:46:23 UTC 14.5K followers, XX engagements

"Redeye comments on Avensias Q2 report with sales and EBIT somewhat lower than anticipated. However Avensia continues to do relatively well in the soft market. $AVEN"
@Redeye_ on X 2025-07-17 12:31:39 UTC 14.5K followers, XXX engagements

"Redeye comments on Synact Pharma's conversion of warrants and Cantargia's deal yesterday. $SYNACT"
@Redeye_ on X 2025-07-16 08:09:02 UTC 14.5K followers, 1075 engagements

"Redeye comments on Verve Groups Q1 2025 results which were in line with expectations in terms of top-line but below expectations in terms of profitability. $VER"
@Redeye_ on X 2025-05-28 07:25:16 UTC 14.5K followers, 1943 engagements

"Redeye updates its Base Case and forecasts for Lime following the Q2 report. $LIME"
@Redeye_ on X 2025-07-14 06:06:01 UTC 14.5K followers, XXX engagements

"Redeye updates its estimates and valuation after Indutrades Q2 2025 report. $INDT"
@Redeye_ on X 2025-07-16 05:08:56 UTC 14.5K followers, 1215 engagements

"Redeye comments on the negative topline data in the TRIFOUR study and provides a new base case for Cantargia. $CANTA"
@Redeye_ on X 2025-07-18 07:00:17 UTC 14.5K followers, 1565 engagements

"Redeye gives its initial take on BONESUPPORTs Q2 report. $BONEX"
@Redeye_ on X 2025-07-15 07:29:21 UTC 14.5K followers, 1378 engagements

"GiG's Q4 2022 report came in higher than Redeye's forecast. In addition the company announced that it is initiating a strategic review to split the business into two independent listed companies: $GIGSEK"
@Redeye_ on X 2023-02-15 08:52:04 UTC 14.5K followers, XX engagements

"Redeye provides a brief comment on the publication of an article in the journal Lung Cancer. $CANTA"
@Redeye_ on X 2025-07-17 07:09:28 UTC 14.5K followers, 2056 engagements

"Redeye comments on Cantargias license deal with Otsaka Pharmaceutical which is transformative for the company since it means both CAN10 (the deal's target) and nadunolimab (the main candidate) are now funded. $CANTA"
@Redeye_ on X 2025-07-15 08:29:55 UTC 14.5K followers, 2492 engagements

"Redeye har intervjuat Fredrik Lundberg vd fr Waystream i samband med deras Q2-rapport. $WAYS"
@Redeye_ on X 2025-07-10 15:51:07 UTC 14.5K followers, 1000 engagements

"Redeye comments on this morning's press release from Arise stating that it has reached an agreement with Foresight regarding the earn-out payment for Klvallen of approx. EUR30m. $ARISE"
@Redeye_ on X 2025-07-16 08:10:13 UTC 14.5K followers, 1190 engagements

"Redeye nudges down its estimates and valuation following Lifcos Q2 2025 report. $LIFCO"
@Redeye_ on X 2025-07-15 06:07:46 UTC 14.5K followers, 1094 engagements

"Redeye recently initiated coverage of Indutrade and we interviewed analyst Christian Binder who talked us through the investment case. $INDT"
@Redeye_ on X 2025-05-14 06:12:36 UTC 14.5K followers, XXX engagements

"Redeye updates its estimates and valuation for Serstech following the Q2 2025 report. $SERT"
@Redeye_ on X 2025-07-17 07:13:58 UTC 14.5K followers, XXX engagements

"Redeye retains its positive view of CombinedX following a relatively soft Q2. $CX"
@Redeye_ on X 2025-07-18 12:17:36 UTC 14.5K followers, XXX engagements

"Redeye provides its initial take on Indutrades Q2 2025 report which came in below our estimates. $INDT"
@Redeye_ on X 2025-07-15 06:37:24 UTC 14.5K followers, 1186 engagements

"Redeye provides an update following SSH's Q2 2025 were sales increased by XXX% y/y to EUR5.4m with a EBITDA margin of 7.7%. Operating cash flow was EUR-06m and PrivX grew by 15.1%. $SSH1V"
@Redeye_ on X 2025-07-18 06:57:24 UTC 14.5K followers, XXX engagements

"Redeye comments on Invisio ahead of Q2-results (due XX July) where we expect sequential improvement after soft performance in Q1. $IVSO"
@Redeye_ on X 2025-07-10 07:01:20 UTC 14.5K followers, XXX engagements

"Redeye initiates coverage of Indutrade one of the largest Swedish niche acquirers which has successfully implemented serial acquisition at scale in recent decades. $INDT"
@Redeye_ on X 2025-05-05 06:29:08 UTC 14.5K followers, 1102 engagements

"Redeye comments on Infracom confirming yesterday that Bredband2 is the underlying investment for its total return swap (TRS). $INFRA"
@Redeye_ on X 2025-07-02 08:55:43 UTC 14.5K followers, 1436 engagements

"Redeye will have a live update with Cantargia at XXXXX in which we will interview CEO Damian Marron about the deal with Otsuka Pharmaceutical. $CANTA"
@Redeye_ on X 2025-07-15 11:38:59 UTC 14.5K followers, 1699 engagements

"Redeye interviews Calliditas' CEO Rene Aguiar-Lucander after securing full FDA approval for Tarpeyo. $CALTX"
@Redeye_ on X 2023-12-22 07:12:27 UTC 14.5K followers, 3129 engagements

"Redeye provides its first take on Cellavisions Q2 report 2025 published this morning. $CEVI"
@Redeye_ on X 2025-07-18 07:16:42 UTC 14.5K followers, XXX engagements

"Redeye comments on Avtech's reported preliminary Q2 2025 net sales of SEK11.8m and an EBITDA of SEK5.5m marking year-on-year growth of XX% for both metrics and an EBITDA margin of 42%. $AVT"
@Redeye_ on X 2025-07-07 05:58:08 UTC 14.5K followers, 1110 engagements

"Redeye provides an initial take on Waystreams Q2 numbers that were presented this morning which came in stronger than expected. $WAYS"
@Redeye_ on X 2025-07-10 07:03:36 UTC 14.5K followers, 1027 engagements

"Redeye comments on Vitrolife facing a tough start in 2025 and we expect this to continue during H1 2025. $VITR"
@Redeye_ on X 2025-04-24 11:20:02 UTC 14.5K followers, XXX engagements

"Redeye states that the Q2 report came in broadly in line with our expectations with a high YoY net sales growth of XX% and even as high as XX% FX-adjusted. $SIVE"
@Redeye_ on X 2025-07-17 07:21:01 UTC 14.5K followers, XXX engagements

"Redeye interviews Hansa Biopharma's CEO Rene Aguiar-Lucander after her very intense first two months with the company. $HNSA"
@Redeye_ on X 2025-06-27 12:12:56 UTC 14.5K followers, 11.8K engagements

"Redeye comments on Vitrolife facing a tough 2025 and we expect this to continue during H2 2025 at best at a fading rate. $VITR"
@Redeye_ on X 2025-07-17 12:31:10 UTC 14.5K followers, XXX engagements

"Redeye comments on Hansa being in a better position to support its main value drivers engage in strategic priorities and potentially extend the number of commercial and clinical partners over the next 6-12 months. $HNSA"
@Redeye_ on X 2025-07-17 07:25:22 UTC 14.5K followers, 1000 engagements

"Redeye provides an initial comment on the Q2 2025 report from Serstech. $SERT"
@Redeye_ on X 2025-07-16 08:09:30 UTC 14.5K followers, XXX engagements

"Redeye publishes a preview of Transtemas Q2 report. $TRANS"
@Redeye_ on X 2025-07-10 06:58:52 UTC 14.5K followers, XXX engagements

"Redeye provides its initial take on Lifcos Q2 2025 report which came in below our estimates. $LIFCO"
@Redeye_ on X 2025-07-14 06:08:50 UTC 14.5K followers, 1671 engagements

"Redeye returns with a more in-depth take on Bonesupport's Q2 report. $BONEX"
@Redeye_ on X 2025-07-16 06:09:26 UTC 14.5K followers, 1292 engagements

"Redeye updates on InfraCom following Telias bid for Bredband2 at SEK3.25 per share InfraCom has agreed to tender its shares. $INFRA"
@Redeye_ on X 2025-07-18 07:21:58 UTC 14.5K followers, 1227 engagements

"Redeye comments on Arises Q2 report which saw higher production than expected driving the segment's earnings generation. $ARISE"
@Redeye_ on X 2025-07-18 09:59:13 UTC 14.5K followers, XXX engagements

"Indutrade is trading below Redeye's Base Case. We had a chat with our analyst where we discussed the factors driving Indutrade's high success rate in past M&A deals preservation of Indutrade's decentralised culture and more. This is a premium article included in our paid plans from SEK 99/month. $INDT"
@Redeye_ on X 2025-06-17 08:42:24 UTC 14.5K followers, XXX engagements

"Redeye lifts its ARR and EBITDA-CAPEX estimates for Litium after the Q2 report where ARR growth significantly exceeded expectations. $LITI"
@Redeye_ on X 2025-07-10 07:00:25 UTC 14.5K followers, XXX engagements

"Redeye interviews Vitecs CEO Olle Backman. We discuss the companys Q2 2025 report this quarters tough comparables for Enova and prospects for H2 2025. $VIT"
@Redeye_ on X 2025-07-11 13:49:58 UTC 14.5K followers, 1163 engagements

"Redeye updates its production estimates ahead of Arise's Q2 report on Friday next week (18 July). $ARISE"
@Redeye_ on X 2025-07-11 06:14:24 UTC 14.5K followers, XXX engagements